Showing results (21-30 of 325) with videos related to

Sort By:
Pageof 33
International Clinical Psychopharmacology|May 9, 2018
Pharmacological treatment of sexual offenders in German outpatient treatment centersDaniel Turner, Priscilla Gregório Hertz, Julia Sauter, et al.
Journal of Sex & Marital Therapy|July 25, 2018
Validation of the Change or Stop Testosterone-Lowering Medication (COSTLow) Scale Using the Delphi Method Among Clinical ExpertsPeer Briken, Daniel Turner, Florence Thibaut, et al.
The Journal of Sexual Medicine|March 2, 2023
Changing or stopping testosterone-lowering medication in men convicted of sexual offenses: clinical evaluation of the COSTLow-R ScaleJochen Wolba, Safiye Tozdan, Peer Briken, et al.
Behavioral Sciences & the Law|March 14, 2012
Assessment of accused juvenile sex offenders in Germany: a comparison of five different measuresVerena Klein, Dahlnym Yoon, Peer Briken, et al.
Sexual Abuse : a Journal of Research and Treatment|December 21, 2024
Is Stopping of Testosterone-Lowering Medication in Men Convicted of Sexual Offenses Associated With an Increase in Recidivism Risk?Jochen Wolba, Daniel Turner, Peer Briken, et al.
Sexual Abuse : a Journal of Research and Treatment|December 21, 2014
Risk Assessment in Child Sexual Abusers Working With ChildrenDaniel Turner, Martin Rettenberger, Dahlnym Yoon, et al.
The Journal of Sexual Medicine|April 7, 2025
Changing or stopping testosterone-lowering medication in men convicted of sexual offenses: clinical evaluation of the COSTLow-R scaleJochen Wolba, Safiye Tozdan, Peer Briken, et al.
International Journal of Offender Therapy and Comparative Criminology|August 18, 2016
Factors Predicting Desistance From Reoffending: A Validation Study of the SAPROF in Sexual OffendersDahlnym Yoon, Daniel Turner, Verena Klein, et al.
Dialogues in Clinical Neuroscience|June 5, 2024
The impact of testosterone-lowering medication on recidivism in individuals convicted of sexual offensesJulia Sauter, Laura M Lingenti, Martin Rettenberger, et al.
Pageof 33